Sharci-dajiyayaasha California ayaa si dirqi ah u ansixiyay sharci Khamiista. Soo jeedinta waxaa taageeray mujaahidiinta iyo u doodayaasha dib u habeynta cadaaladda dembiyada si loo xakumo lahaanshaha iyo isticmaalka shakhsi ahaaneed ee liiska xaddidan ee cilmi nafsiga dabiiciga ah, oo ay ku jiraan "boqoshaada sixirka."
Guddoomiyaha Gavin Newsom ayaa hadda go'aamin doona masiirka sharciga Senate-ka ee 58, kaas oo meesha ka saaraya ciqaabta dambiyada ee haysashada iyo isticmaalka psilocybin iyo psilocin, maaddooyinka firfircoon ee boqoshaada dhimirka. Sharciga ayaa sidoo kale khuseeya mescaline iyo dimethyltryptamine (DMT).
Sharcigu wuxuu u baahan yahay Hay'adda Adeegyada Caafimaadka iyo Aadanaha ee Kaliforniya inay baarto isticmaalka daawaynta ee cilmi-nafsiga oo ay u soo gudbiso warbixin leh natiijooyin iyo talooyin sharci-dejinta. Qiyaasta ayaa ku meel marisay Senate-ka 21-14 cod, iyadoo dhowr dimuqraadi ah ay ka soo horjeesteen.
Taagerayaasha cilmi nafsiga
"Julyada California, jawaabayaasha ugu horreeya iyo kuwa kale ee la halgamaya PTSD, niyad-jabka iyo qabatinka waxay u qalmaan inay helaan daawooyinkan dhirta ku salaysan ee ballanqaadka ah," Sen. codayn . 42-11 cod "Waxaa la joogaa waqtigii la joojin lahaa dambiyada dadka maskaxiyan u isticmaal bogsashada ama wanaagga shakhsi ahaaneed."
Cabbirku waxa uu khuseeyaa oo keliya dadka da'doodu tahay 21 iyo ka weyn mana oggola beddelka shakhsi ahaaneed ama iibinta dhakhaatiirta dhimirka ee farmashiyaha. Oakland iyo Santa Cruz waxay qaadeen tillaabooyin la mid ah. U doodayaasha dib-u-habaynta cadaaladda dembiyada ayaa sheegaya in dembiilayaasha dhimirka ay tahay tallaabo lagu soo afjarayo dagaalka ka dhanka ah daroogada.
Kooxaha mujaahidiinta ayaa sheegaya in ay ka caawin doonto hoos u dhigista dhakhaatiirta dhimirka, kuwaas oo xaaladaha qaarkood ay aad uga waxtar badan yihiin daawaynta xanuunka kadeedka ka dib, welwelka iyo niyad-jabka marka loo eego daawooyinka dhaqameed. iyo daawaynta. Horumarkan wanaagsani sidoo kale ma u horseedi doonaa Yurub mustaqbalka?
Xigasho: latimes.com (EN)
